Aclaris Therapeutics, Inc.
USD5.68
+0.32 (+5.97%)
CEO
Neal S. Walker
IPO Date
2015-10-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.28
Prev. Close
$5.36
Day Low
$5.25
Day High
$5.70
52W Low
$1.46
52W High
$5.85
Market Cap
$0.68B
Volume
1.25M
| 42,350 |
| $4.71 |
| 8 Jun 2026 | Mehra Anand | director | A-Award | Acquired | 10,987 | $0.00 |
| 8 Jun 2026 | Mehra Anand | director | M-Exempt | Disposed | 11,580 | $0.00 |
| 8 Jun 2026 | SCHIFF ANDREW N | director | M-Exempt | Acquired | 11,580 | $0.00 |
| 8 Jun 2026 | SCHIFF ANDREW N | director | A-Award | Acquired | 42,350 | $4.71 |
| 8 Jun 2026 | SCHIFF ANDREW N | director | A-Award | Acquired | 10,987 | $0.00 |
| 8 Jun 2026 | SCHIFF ANDREW N | director | M-Exempt | Disposed | 11,580 | $0.00 |
| 8 Jun 2026 | Humphries William D. | director | M-Exempt | Acquired | 11,580 | $0.00 |
| 8 Jun 2026 | Humphries William D. | director | A-Award | Acquired | 42,350 | $4.71 |